Suramin in Treating Patients With Recurrent Primary Brain Tumors

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1995

Study Completion Date

May 31, 2004

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

chemotherapy

DRUG

suramin

Trial Locations (1)

Department of Neurosurgery - Emory, Atlanta

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER

NCT00002639 - Suramin in Treating Patients With Recurrent Primary Brain Tumors | Biotech Hunter | Biotech Hunter